Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended		78 Months Ended
	Apr. 30, 2012	Apr. 30, 2011	Apr. 30, 2012
Cash flows from operating activities:
Net loss	$ (818,619)	$ (763,623)	$ (17,171,408)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	14,218	12,498	154,666
Amortization of costs and fees related to convertible debentures	214,152	143,278	1,017,899
Common stock issued for services		750	2,144,790
Common stock issued to officers and directors for services	79,580	66,000	3,158,275
Common stock issued for shares of subsidiary stock		71,000	254,000
Common stock of subsidiary issued to employees and consultants			2,815
Common stock issued as a commission			3,000
Common stock issued for accounts payable	455,459		752,042
Common stock issued to former licensee			41,319
Common stock issued/recovered on cancelled agreements			20,478
Non-cash compensation for stock options and warrants			631,923
Costs and fees related to issuance of convertible debt	3,288		542,540
Interest expense related to beneficial conversion feature			1,944,800
Interest paid with common stock	35,876		154,363
Interest on notes receivable for common stock			(1,373)
(Increase) decrease in assets
Prepaid expenses		74,069	25,371
Inventories
Notes receivable		(35,000)
Increase -decrease in liabilities:
Derivate liability	(70,404)		105,461
Trade accounts payable	(46,096)	89,311	570,448
Accounts payable to officers and directors	(292,386)	94,029	367,696
Accrued payroll and other expenses	55,564	55,753	316,881
Net cash used in operating activities	(369,368)	(191,935)	(4,964,014)
Cash flows from investing activities:
Purchase of fixed assets	(4,256)		(217,398)
Net cash used in investing activities	(4,256)		(217,398)
Cash flows from financing activities:
Principal payments on notes payable to stockholder		(25,000)	(1,133,000)
Proceeds from issuance of notes payable to a related party	60,000	4,000	1,099,800
Proceeds from issuance of notes and convertible notes payable	75,000	138,868	1,604,234
Proceeds from issuance of common stock	273,813	61,072	2,455,475
Net cash provided by financing activities	408,813	178,940	4,026,509
Net change in cash	35,189	(12,995)	(1,154,903)
Cash at beginning of period	5,206	(7,876)	1,195,298
Cash at end of period	40,395	(20,871)	40,395
Supplemental Disclosure of Cash Flow Information
Interest paid		664	10,985
Income taxes paid	1,600	1,600	20,240
Supplemental Schedule of Non-Cash Investing and Financing Activities
Conversion of convertible notes payable to shares of common stock	290,000	139,865
Notes converted by stockholders	$ 206,500